Effect of BCG Treatment on Airway Inflammation and T Regulatory Cell of Asthma Mouse

Yu XIA,Jiang-hua ZHANG,Zhen-hua JI,Xiao-di LI,Zhi-wei YU,Hai-yan LIU
DOI: https://doi.org/10.3969/j.issn.1673-0399.2007.01.020
2007-01-01
Abstract:Objective To explore the effect of BCG treatment on T regulatory cell of asthma mouse.Methods Twenty four Kunming mouse were randomly divided into asthma group,BCG treatment group and control group.Kunming mouse were sensitized and challenged with OVA to establish asthma model.Asthma mouse in BCG treatment group were injected intradermally with BCG 5 days before and after sensitization.The mice in control group were challenged with saline.After 24 hours of last challenge,bronchoaveolar lavage fluid(BALF)and peripheral blood were collected.The total cells and eosinophils were counted in BALF.The percentage of CD4+CD25+in peripheral blood was analyzed with flow cytometry.Single spleen cell suspension was prepared and cultured in 1640 medium,after 48 hours,supernatant was harvested and the level of cytokine IL-10 was determined by Elisa.Results Compared with the normal control group,the total cells and eosinophils in BALF were more in asthma mouse(P< 0.01).The number of total cells and eosinophils in BALF were reduced in asthma mouse treated with BCG compared with asthma mouse(P< 0.01).The percentage of CD4+CD25+in peripheral blood of asthma mouse(11.59±1.33)%was lower than that in the control group(13.66±1.68)%(P< 0.01).The percentage of CD4+CD25+in asthma mouse treated with BCG(14.4±2.75)%was higher than asthma mouse(P< 0.05).The level of IL-10 in spleen cell supernatant within BCG group(7.79±1.34 pg/ml)was also elevated contrasted with asthma mouse(5.54±0.66 pg/ml)(P< 0.01).Conclusion BCG can markly inhabit airway inflammation of asthma mouse by mechanism that promote the production of regulatory T cell.
What problem does this paper attempt to address?